鈣拮抗劑的全球市場規模調查&預測:藥物類別，流通管道(醫院，零售藥局，其他)，各地區分析，2022-2029年

鈣通道阻滯劑是一類通過阻止鈣進入心臟和動脈細胞來降低血壓的藥物。

市場增長是由心血管疾病上升和口服藥物需求增加等關鍵因素推動的。

本調查的目的是定義近年來各個細分市場和國家的市場規模，並在未來幾年預測它們的價值。本報告設計內容涵蓋調查對像國家產業的定性和定量雙方面。

此外也提供市場未來性的成長促進因素和課題等重要方面相關之詳細資訊。再加上主要企業的競爭情形和提供產品之詳細分析，並涵括利害關係者投資所需的微觀市場潛在機會。詳細的市場區隔和子區隔如下列。

各藥物類別

二氫吡啶

苯並西平

苯烷基胺

各銷售管道

醫院

零售藥局

其他

各地區

北美

美國

加拿大

歐洲

英國

德國

法國

西班牙

義大利

其他歐洲

亞太地區

中國

印度

日本

澳洲

韓國

其他亞太地區

南美

巴西

墨西哥

全球其他地區

目錄

第1章 摘要整理

• 市場概述
• 世界·市場區隔市場估計·預測，2019-2029年
  • 鈣拮抗劑市場:各地區，2019年～2029年
  • 鈣拮抗劑市場:各藥物類別，2019年～2029年
  • 鈣拮抗劑市場:各流通管道，2019-2029年
• 主要趨勢
• 調查手法的介紹
• 調查前提條件

第2章 鈣拮抗劑的全球市場:定義和範圍

• 調查的目的
• 市場定義和範圍
  • 調查目標範圍
  • 產業的演進
• 調查對像年
• 貨幣換算比率

第3章 鈣拮抗劑的全球市場動態

• 鈣拮抗劑市場影響分析(2019-2029年)
  • 推動市場要素
  • 市場課題
  • 市場機會

第4章 鈣拮抗劑的全球市場:產業分析

• 波特的5力模式
  • 供給企業談判力
  • 買方議價能力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭企業間的敵對關係
• 波特五力分析的未來性方法(2019-2029年)
• PEST分析
  • 政治
  • 經濟
  • 社會
  • 技術性
• 投資採用模式
• 分析師的結論·建議
• 頂級投資機會
• 主要成功策略

第5章 風險評估:COVID-19衝擊

• COVID-19對產業帶來的整體影響的評估
• COVID-19以前和COVID-19以後的市場情景

第6章 鈣拮抗劑的全球市場:各藥物類別

• 市場概述
• 鈣拮抗劑的全球市場，各藥物類別，業績-潛在力分析
• 鈣拮抗劑的全球市場，各藥物類別估計·預測2019～2029年
• 鈣拮抗劑市場，子區隔分析
  • 二氫吡啶
  • 苯並西平
  • 苯烷基胺

第7章 鈣拮抗劑的全球市場:各流通管道

• 市場概述
• 鈣拮抗劑的全球市場:各流通管道，實際成果-潛在力分析
• 鈣拮抗劑的全球市場:各流通管道估計·預測2019～2029年
• 鈣拮抗劑的全球市場:子區隔分析
  • 醫院
  • 零售藥局
  • 其他

第8章 鈣拮抗劑的全球市場:各地區分析

• 鈣拮抗劑市場，各地區市場概述
• 北美
  • 美國
    • 各藥物類別的估計·預測，2019年～2029年
    • 各流通管道的估計·預測，2019年～2029年
  • 加拿大
• 歐洲的鈣拮抗劑市場概述
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 義大利
  • 其他的歐洲地區
• 亞太地區的鈣拮抗劑市場概述
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 其他亞太地區
• 南美的鈣拮抗劑市場概述
  • 巴西
  • 墨西哥
• 全球其他地區

第9章 競爭資訊

• 頂級市場策略
• 企業簡介
  • Bausch Health Company Inc.
    • 主要的資訊
    • 概要
    • 財務(視資料可得性)
    • 產品概要
    • 最近的開發情形
  • Abbvie Inc
  • Lupin Pharmaceuticals, Inc
  • Arbor Pharmaceuticals LLC
  • Alvogen
  • Exela Pharma Sciences, LLC
  • Covis Pharma BV
  • Novartis AG
  • GlaxoSmithKline LLC
  • Pfizer Inc

第10章 調查流程

• 調查流程
  • 資料探勘
  • 分析
  • 市場估計
  • 驗證
  • 出版
• 調查屬性
• 調查前提條件

Global Calcium Channel Blocker Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2022-2029. Calcium channel blockers are a class of drugs that lower blood pressure by stopping calcium from entering heart and artery cells. Stronger cardiac muscle contractions are caused by calcium. Calcium channel blockers facilitate this by allowing blood arteries to relax, which increases the flow of blood and ensures that the heart receives the necessary amount of oxygen. The market growth is driven by significant factors such as increase in cardiovascular diseases and rising demand for Oral Drugs.

Heart failure is a chronic, incapacitating cardio-renal-metabolic condition that affects at least 60 million people globally, according to a news release published by Boehringer Ingelheim GmbH in August 2021. There is an urgent need for novel treatment alternatives as heart failure prevalence rises. Additionally, the market is anticipated to rise due to rising hypertension rates, an increase in hospitals, and government efforts. For instance, the American Hospital Association estimates that there were 6,090 hospitals in the United States as of 2021. According to data updated by the World Health Organization (WHO) in August 2021, more than 700 million people worldwide have untreated hypertension, and as of that year, 1.28 billion people worldwide had hypertension, a sharp increase over the previous few decades. However, lack of skilled professionals' stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Calcium Channel Blocker Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is expected to hold a major market share owing to increasing prevalence rate of cardiovascular diseases. However, Asia Pacific is expected to be the fastest growing region due to large number of generic manufacturer and developing healthcare facilities.

Major market players included in this report are:

Bausch Health Company Inc.

Abbvie Inc

Lupin Pharmaceuticals, Inc

Arbor Pharmaceuticals LLC

Alvogen

Exela Pharma Sciences, LLC

Covis Pharma BV

Novartis AG

GlaxoSmithKline LLC

Pfizer Inc

Recent Developments in the Market:

• The FDA approved Norliqva (amlodipine) oral solution in February 2022 to treatment hypertension in adults and children aged 6 and older, as well as to prevent coronary artery disease.
• The American Food and Drug Administration (FDA) received provisional permission in May 2022 for Zydus Worldwide DMCC's subsidiary to commercialize Selexipag tablets for the treatment of pulmonary arterial hypertension (PAH) in adults.

Global Calcium Channel Blocker Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Drug Class, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Dihydropyridine

Benzothizepine

Phenylalkylamine

By Distribution Channel:

Hospitals

Retail Pharmacies

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Calcium Channel Blocker Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Calcium Channel Blocker Market, by Drug Class, 2019-2029 (USD Billion)
  • 1.2.3. Calcium Channel Blocker Market, by Distribution Channel, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Calcium Channel Blocker Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Calcium Channel Blocker Market Dynamics

• 3.1. Calcium Channel Blocker Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increase in Cardiovascular Diseases
    • 3.1.1.2. Rising demand for oral drugs
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack of skilled professionals
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing demand for retail pharmacies
    • 3.1.3.2. Increased clinical studies and government initiatives

Chapter 4. Global Calcium Channel Blocker Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Calcium Channel Blocker Market, by Drug Class

• 6.1. Market Snapshot
• 6.2. Global Calcium Channel Blocker Market by Drug Class, Performance - Potential Analysis
• 6.3. Global Calcium Channel Blocker Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
• 6.4. Calcium Channel Blocker Market, Sub Segment Analysis
  • 6.4.1. Dihydropyridine
  • 6.4.2. Benzothizepine
  • 6.4.3. Phenylalkylamine

Chapter 7. Global Calcium Channel Blocker Market, by Distribution Channel

• 7.1. Market Snapshot
• 7.2. Global Calcium Channel Blocker Market by Distribution Channel, Performance - Potential Analysis
• 7.3. Global Calcium Channel Blocker Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
• 7.4. Calcium Channel Blocker Market, Sub Segment Analysis
  • 7.4.1. Hospitals
  • 7.4.2. Retail Pharmacies
  • 7.4.3. Others

Chapter 8. Global Calcium Channel Blocker Market, Regional Analysis

• 8.1. Calcium Channel Blocker Market, Regional Market Snapshot
• 8.2. North America Calcium Channel Blocker Market
  • 8.2.1. U.S. Calcium Channel Blocker Market
    • 8.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Calcium Channel Blocker Market
• 8.3. Europe Calcium Channel Blocker Market Snapshot
  • 8.3.1. U.K. Calcium Channel Blocker Market
  • 8.3.2. Germany Calcium Channel Blocker Market
  • 8.3.3. France Calcium Channel Blocker Market
  • 8.3.4. Spain Calcium Channel Blocker Market
  • 8.3.5. Italy Calcium Channel Blocker Market
  • 8.3.6. Rest of Europe Calcium Channel Blocker Market
• 8.4. Asia-Pacific Calcium Channel Blocker Market Snapshot
  • 8.4.1. China Calcium Channel Blocker Market
  • 8.4.2. India Calcium Channel Blocker Market
  • 8.4.3. Japan Calcium Channel Blocker Market
  • 8.4.4. Australia Calcium Channel Blocker Market
  • 8.4.5. South Korea Calcium Channel Blocker Market
  • 8.4.6. Rest of Asia Pacific Calcium Channel Blocker Market
• 8.5. Latin America Calcium Channel Blocker Market Snapshot
  • 8.5.1. Brazil Calcium Channel Blocker Market
  • 8.5.2. Mexico Calcium Channel Blocker Market
• 8.6. Rest of The World Calcium Channel Blocker Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Bausch Health Company Inc.
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Abbvie Inc
  • 9.2.3. Lupin Pharmaceuticals, Inc
  • 9.2.4. Arbor Pharmaceuticals LLC
  • 9.2.5. Alvogen
  • 9.2.6. Exela Pharma Sciences, LLC
  • 9.2.7. Covis Pharma BV
  • 9.2.8. Novartis AG
  • 9.2.9. GlaxoSmithKline LLC
  • 9.2.10. Pfizer Inc

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Calcium Channel Blocker Market, report scope
• TABLE 2. Global Calcium Channel Blocker Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Calcium Channel Blocker Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
• TABLE 4. Global Calcium Channel Blocker Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
• TABLE 5. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Calcium Channel Blocker Market
• TABLE 70. List of primary sources, used in the study of global Calcium Channel Blocker Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Calcium Channel Blocker Market, research methodology
• FIG 2. Global Calcium Channel Blocker Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Calcium Channel Blocker Market, key trends 2021
• FIG 5. Global Calcium Channel Blocker Market, growth prospects 2022-2029
• FIG 6. Global Calcium Channel Blocker Market, porters 5 force model
• FIG 7. Global Calcium Channel Blocker Market, pest analysis
• FIG 8. Global Calcium Channel Blocker Market, value chain analysis
• FIG 9. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Calcium Channel Blocker Market, regional snapshot 2019 & 2029
• FIG 15. North America Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
• FIG 19. Global Calcium Channel Blocker Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable